Due to previous studies suggesting that IFNγ plays a critical role in the pathogenesis of AD21, we evaluated the expression levels of IFNγ in AD patients and APP/PS1 transgenic mice at 6 or 9 months of age. Here, APP is linked to Alzheimer disease.